Safety Data SheetChemical Risk Assessment

Durvalumab

by AstraZeneca

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Durvalumab is supplied by AstraZeneca under product code 21043. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under NOHSC regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 15 November 2019. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
NOHSC
Revision Date
15 Nov 2019
Signal Word
Product Code
21043
CAS Number
1428935-60-7

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: -

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US